Delivery Order SPE2DB25D9363-SPE2DB25FUFSW

Award Date 7/8/25
Potential Completion Date 7/29/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,712.23 firm fixed-price delivery order is for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,712.23 firm fixed-price delivery order is for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, with a completion date of May 14, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,848.92 firm fixed-price delivery order is for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, with a completion date of June 18, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,712.23 firm fixed-price delivery order is for Xolair 300 mg/2 ml autoinjector 2 ml and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,683.45 firm fixed-price delivery order is for the supply of Xolair 300 mg/2 ml autoinjectors, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $17,122.20, is for the delivery of XOLAIR 150 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract is a firm fixed-price Delivery Order without any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,848.92 firm fixed-price delivery order is for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,424.46 firm fixed-price delivery order is for the supply of Xolair 300 mg/2 ml autoinjectors. The contract has an ultimate completion date of November 14, 2024 and is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 single-award Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,410.04 firm fixed-price delivery order is for the provision of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a specialized pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,424.46 firm fixed-price delivery order is for the supply of Xolair 300 mg/2 ml autoinjector 2 ml and does not have a set-aside designation. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
  • SPE2DB25D9363
    Indefinite Delivery Contract
  • SPE2DB25D9363-SPE2DB25FUFSW
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,424.44 firm fixed-price delivery order is for XOLAIR 150 MG/ML AUTOINJECTORML and does not have a set-aside designation.

DMS Pharmaceutical Group Inc. holds a significant $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items supporting the medical supply needs of military health facilities worldwide. This positioning establishes DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.

Generated 10/12/25, 12:47 AM